GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Blair William & Co. IL

Blair William & Co. IL reduced its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 108,621 shares of the company’s stock after selling 1,752 shares during the quarter. Blair William & Co. IL’s holdings in GE HealthCare Technologies were worth $8,492,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the business. FMR LLC lifted its holdings in shares of GE HealthCare Technologies by 4.1% during the 3rd quarter. FMR LLC now owns 2,165,826 shares of the company’s stock worth $203,263,000 after acquiring an additional 84,411 shares during the period. Townsquare Capital LLC increased its position in GE HealthCare Technologies by 21.5% during the third quarter. Townsquare Capital LLC now owns 7,722 shares of the company’s stock worth $725,000 after purchasing an additional 1,366 shares during the last quarter. Glenmede Trust Co. NA raised its stake in GE HealthCare Technologies by 0.6% during the third quarter. Glenmede Trust Co. NA now owns 30,173 shares of the company’s stock worth $2,832,000 after purchasing an additional 180 shares during the period. Healthcare of Ontario Pension Plan Trust Fund acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at $2,799,000. Finally, CreativeOne Wealth LLC purchased a new stake in shares of GE HealthCare Technologies during the 3rd quarter valued at $259,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $80.01 on Friday. The firm has a market cap of $36.59 billion, a price-to-earnings ratio of 18.48, a PEG ratio of 3.19 and a beta of 1.13. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The business’s 50 day moving average is $86.70 and its two-hundred day moving average is $85.87. GE HealthCare Technologies Inc. has a 52-week low of $74.51 and a 52-week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. Analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.17%. The ex-dividend date is Friday, April 25th. GE HealthCare Technologies’s dividend payout ratio is currently 3.23%.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. The Goldman Sachs Group upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and lifted their target price for the company from $85.00 to $100.00 in a report on Tuesday, March 11th. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their target price for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Wells Fargo & Company raised their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, February 14th. Finally, Citigroup increased their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $98.75.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.